Zydus Lifesciences' Q3 Net Profit Rises 1.81% to Rs 1,042 Crore
Loading more articles...
Zydus Lifesciences Q3 Net Profit Jumps 1.81% to Rs 1,042 Cr
N
News18•09-02-2026, 14:00
Zydus Lifesciences Q3 Net Profit Jumps 1.81% to Rs 1,042 Cr
•Zydus Lifesciences reported a 1.81% rise in consolidated net profit, reaching Rs 1,042.1 crore for Q3 ended December 31, 2025.
•Consolidated total revenue from operations surged to Rs 6,864.5 crore, up from Rs 5,269.1 crore in the year-ago period.
•Total expenses increased to Rs 5,537.6 crore, including a one-time impact of Rs 84.9 crore due to a new labor code.
•The pharmaceuticals segment revenue grew to Rs 5,900.3 crore, with strong performance in India's branded formulations, US business, and international markets.